John Paulson Pacira Bio Sciences, Inc. Transaction History

Paulson & Co. Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$51.49 - $81.64 $7.72 Million - $12.2 Million	-150,000 Reduced 30.0%	350,000 $20.4 Million
Q1 2022 May 16, 2022	SELL	$60.03 - $76.49 $72.4 Million - $92.2 Million	-1,205,599 Reduced 70.68%	500,000 $38.2 Million
Q4 2021 Feb 14, 2022	BUY	$47.97 - $62.21 $21.4 Million - $27.8 Million	446,081 Added 35.42%	1,705,599 $103 Million
Q3 2021 Nov 15, 2021	SELL	$54.64 - $61.3 $745,453 - $836,315	-13,643 Reduced 1.07%	1,259,518 $70.5 Million
Q2 2021 Aug 16, 2021	SELL	$59.18 - $69.99 $8.33 Million - $9.85 Million	-140,693 Reduced 9.95%	1,273,161 $77.3 Million
Q4 2020 Feb 16, 2021	BUY	$50.47 - $66.26 $7.99 Million - $10.5 Million	158,246 Added 12.6%	1,413,854 $84.6 Million
Q3 2020 Nov 16, 2020	SELL	$51.97 - $63.0 $1.78 Million - $2.16 Million	-34,333 Reduced 2.66%	1,255,608 $75.5 Million
Q2 2020 Aug 14, 2020	SELL	$30.8 - $52.47 $13.1 Million - $22.4 Million	-426,786 Reduced 24.86%	1,289,941 $67.7 Million
Q3 2019 Nov 14, 2019	BUY	$35.66 - $44.99 $27 Million - $34.1 Million	757,730 Added 79.01%	1,716,727 $65.4 Million
Q2 2019 Aug 14, 2019	BUY	$36.57 - $47.97 $25.9 Million - $34 Million	708,997 Added 283.6%	958,997 $41.7 Million
Q1 2019 May 15, 2019	BUY	$36.47 - $42.17 $9.12 Million - $10.5 Million	250,000 New	250,000 $9.52 Million

263

50.4M

429K

391K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $892M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Paulson & Co. Inc., based on Form 13F filings with the SEC.

Stay updated on Paulson & Co. Inc. and John Paulson with notifications on news.